Vollaard E J, Clasener H A, Janssen A J
Department of Pharmacy, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
J Antimicrob Chemother. 1990 Sep;26(3):411-8. doi: 10.1093/jac/26.3.411.
The contribution of Escherichia coli to the microbial colonization resistance (CR) of the bowel was investigated in six healthy volunteers. Esch. coli was eliminated from faeces by the administration of a low dose (20 mg daily) of pefloxacin. This did not cause an increase in the faecal concentration of aerobic Gram-positive cocci or yeasts, nor did it facilitate colonization of the bowel by a pefloxacin-resistant challenge strain of Klebsiella pneumoniae. Therefore, Esch. coli does not appear to contribute to the microbial CR. After ten days of pefloxacin, clindamycin 300 mg was administered twice daily for 18 days. Clindamycin caused a significant increase in the faecal concentration of enterococci, yeasts and the K. pneumoniae challenge strain, indicating that the study design was suitable to demonstrate disturbance of microbial CR if it occurred.
在六名健康志愿者中研究了大肠杆菌对肠道微生物定植抗性(CR)的作用。通过给予低剂量(每日20毫克)的培氟沙星从粪便中清除大肠杆菌。这并未导致需氧革兰氏阳性球菌或酵母菌的粪便浓度增加,也未促进肺炎克雷伯菌对培氟沙星耐药的攻击菌株在肠道的定植。因此,大肠杆菌似乎对微生物CR没有作用。在使用培氟沙星十天后,每天两次给予300毫克克林霉素,持续18天。克林霉素导致粪肠球菌、酵母菌和肺炎克雷伯菌攻击菌株的粪便浓度显著增加,表明该研究设计适合于证明微生物CR是否发生了紊乱。